Compare Baidu Inc (BIDU) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baidu Inc vs Nuwellis Inc — how do they compare? Baidu Inc trades at $104.74 (market cap $36.18B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Baidu Inc is far larger — about 66654.4× Nuwellis Inc's market cap, and Baidu Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| BIDU | NUWE | |
|---|---|---|
Market Cap | $36.18B | $542.80K |
Sector | Media | Technology |
52-Week High | $162.52 | $220.50 |
52-Week Low | $86.76 | $1.42 |
Enterprise Value | $32.81B | -$1.27M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baidu (BIDU) trades at $109.50, down 0.19% on the day, with technicals indicating a bearish trend and key support at $108. The company reported a sharp decline in net income to $5.59 billion in 2025, with margins contracting, though it beat EPS estimates in two of the last three quarters. Recent news highlights autonomous vehicle testing in London and a planned Q2 2026 earnings report on August 18, 2026.
The outlook is mixed: strong analyst buy ratings (75.47%) and a $169.80 price target suggest upside, but bearish technicals, profit margin pressures, and China market risks pose challenges. Investment opportunity hinges on AI and cloud growth offsetting advertising weakness, while risks include execution missteps and regulatory headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baidu Inc
Baidu, Inc. operates an Internet search engine. The Company offers algorithmic search, enterprise search, news, MP3, and image searches, voice assistance, online storage, and navigation services. Baidu serves clients globally.
Read more on BIDU →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
